Capillary Electrophoresis (CE) Instrument

Location: Maryland
Posted: Jul 11, 2025
Due: Jul 26, 2025
Agency: COMMERCE, DEPARTMENT OF
Type of Government: Federal
Category:
  • 66 - Instruments and Laboratory Equipment
Solicitation No: NB645030-25-01696
Publication URL: To access bid details, please log in.
Follow
Capillary Electrophoresis (CE) Instrument
Active
Contract Opportunity
Notice ID
NB645030-25-01696
Related Notice
Department/Ind. Agency
COMMERCE, DEPARTMENT OF
Sub-tier
NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY
General Information
  • Contract Opportunity Type: Special Notice (Original)
  • Original Published Date: Jul 11, 2025 09:08 am EDT
  • Original Response Date: Jul 26, 2025 09:00 am EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: Aug 10, 2025
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: 6640 - LABORATORY EQUIPMENT AND SUPPLIES
  • NAICS Code:
    • 334516 - Analytical Laboratory Instrument Manufacturing
  • Place of Performance:
    Rockville , MD 20850
    USA
Description

FBO ANNOUNCEMENT: PRE-SOLICITATION NOTICE, NOTICE OF INTENT





ACTION CODE: SPECIAL NOTICE





CLASSIFICATION CODE: 66 – Instruments and Laboratory Equipment SUBJECT: Capillary Electrophoresis (CE) Analysis Instrument



SOLICITATION NUMBER: NB645030-25-01696





DESCRIPTION:

The National Institute of Standards & Technology (NIST) intends to negotiate on a sole source basis

under the authority of FAR 8.405-6 with AB Sciex, located in Redwood City, California for a CE

Analysis Instrument.





Sole Source justification is based on the following:





NISTs Biomolecular Structure and Function (BSF) group within the Biomolecular Measurement Division

within the Materials Measurement Laboratory (MML) released RM8671 (NISTmAb), a monoclonal antibody reference material generated from a mouse cell line which, represents the largest class of protein therapeutics currently on the market. NISTmAb is used across the biomanufacturing industry as a

standard for developing new analytical platforms and challenging the limits of new technologies.

Prior to its release NISTmAb was throughly characterized using a number of analytical methods. In order to make this reference material longitudinally available, the quality of the material continues to be evaluated at regular intervals so that any changes in the material’s physicochemical properties can be reported to stakeholders.


Attachments/Links
Contact Information
Contracting Office Address
  • US
Primary Point of Contact
Secondary Point of Contact


History
  • Jul 11, 2025 09:08 am EDTSpecial Notice (Original)
Daily notification on new contract opportunities

With GovernmentContracts, you can:

  • Find more opportunities and win more business
  • Receive daily alerts for all new bid opportunities
  • Get contract opportunities matched to your business
ONE WEEK FREE TRIAL

See also

...Follow Measuring mouse body composition Active Contract Opportunity Notice ID 75N98026Q00471...: * Rapid ...

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Bid Due: 6/09/2026

...Follow Renewal of licensing fee for the transgenic mouse strain, B-hIL2RA Active Contract... ...

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Bid Due: 6/08/2026

...of mouse embryos during in utero injection procedures. This capability is essential for ...

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Bid Due: 6/05/2026

* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.